Poolbeg Pharma PLC Announces Immunomodulator I Patent Opposition Withdrawal
Important step in continued protection of Poolbeg's patent familyLONDON, UK / ACCESSWIRE / September 19, 2023 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF)...
Year: 2023
What Ails You? Natural Pain-Relief Tips for 3 Common Aches
STERLING, Ill., Sept. 18, 2023 /PRNewswire/ -- Pain is an unwelcome companion for millions of individuals, and it manifests in...
Tandem Diabetes Care, Inc. (TNDM) Class Action Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Tandem Diabetes Care, Inc. Securities Fraud Class Action
SAN DIEGO--(BUSINESS WIRE)--$TNDM #TNDM--Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who...
Bausch Health Announces CFO Transition Plan
LAVAL, QC / ACCESSWIRE / September 18, 2023 / Bausch Health Companies Inc. (NYSE/TSX:BHC) ("BHC" or the "Company") today announced...
Canntab Therapeutics Limited Provides Update on Application for Management Cease Trade Order
Toronto, Ontario--(Newsfile Corp. - September 18, 2023) - Canntab Therapeutics Limited (CSE: PILL) (OTC Pink: CTABF) (FSE: TBF1) (the "Corporation")...
TNDM INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO--(BUSINESS WIRE)--Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Tandem Diabetes Care, Inc. (NASDAQ: TNDM)...
Wildfire Smoke Provides Stark Reminder of Challenges Faced by Canadian Pulmonary Fibrosis Patients
Many of Canada's 30,000 PF patients who struggle to breathe, can't get the oxygen they need.Markham, Ontario--(Newsfile Corp. - September...
NCQA Unveils 2023 Health Plan Ratings
Successful Reporting of New Direct Race and Ethnicity Measure by 92% of Plans Bodes Well for Improving Health EquityWASHINGTON, DC...
Copient Health Announces ARDEN: The Revolutionary AI Solution for Operating Room Margin Optimization
Generative Artificial Intelligence Solution Unlocks Proprietary Data to Support Perioperative Leaders' Ability to Optimize OR Utilization and Dramatically Increase OR...
Approximately 30% Of Newly Diagnosed Cancers In Women Will Be Breast Cancers – Atossa Therapeutics Has A Promising Drug To Help With Prevention And Treatment
SEATTLE, WA / ACCESSWIRE / September 18, 2023 / One in eight women will be diagnosed with breast cancer during...
Inogen Completes Acquisition of Physio-Assist
Acquisition Expands Inogen’s Global Respiratory Care Presence by Addressing the Sizeable, Growing and Underserved Airway Clearance Market OpportunityGOLETA, Calif.--(BUSINESS WIRE)--Inogen,...
GE HealthCare Awarded a $44 Million Grant to Develop Artificial Intelligence-Assisted Ultrasound Technology Aimed at Improving Outcomes in Low-and-Middle-Income Countries
Grant from Bill & Melinda Gates Foundation will facilitate development of AI-assisted applications and tools to enable healthcare professionals with...
Sonendo to Participate at the Gilmartin Group Emerging Growth Company Showcase
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced...
Three Amwell® Health System Clients to Lead Hybrid Care Panel at Oracle Health Conference
Leaders from Aultman Health, Banner Health and Children’s National Hospital to share successes with Amwell platforms and Oracle Health integrationBOSTON--(BUSINESS...
Biocure Technology Inc. Enters into Exclusive Letter Agreement to Acquire Atriva Therapeutics GmbH in Reverse Takeover Transaction
Vancouver, British Columbia--(Newsfile Corp. - September 18, 2023) - Biocure Technology Inc. (CSE: CURE) ("CURE" or the "Company") announces that...
FloraWorks Announces Updated Analysis of Landmark Clinical Trial; CBN Shown Effective for Sleep
Radicle Science found TruCBN(TM) to significantly improve sleep outcomes in first-ever placebo-controlled trial of pure CBNPortland, Oregon--(Newsfile Corp. - September...
iTolerance, Inc. Bolsters Global Intellectual Property with Issuance of European Patent for Proprietary Regenerative SA-FasL Microgel Technology, iTOL-100
Company leveraging iTOL-100 to advance a pipeline of programs that have the potential to cure diseases, such as Type 1...
Avinger Initiates Full Commercial Launch of Tigereye ST Image-Guided CTO Crossing Device
REDWOOD CITY, CA / ACCESSWIRE / September 18, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the...
Oncocyte’s VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier
Interventional study compares VitaGraft to current transplant rejection monitoring protocolsOncocyte's VitaGraft assay detects antibody-mediated transplant rejection 10 months sooner than...
FSD Pharma announces Interim Results from First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis; The Report Shows Compound to be Safe and Well Tolerated
TORONTO, ON / ACCESSWIRE / September 18, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical...